🇺🇸 FDA
Patent

US 9151762

Identification of DSG-3 as a biomarker for the detection of metastasis in lymph nodes

granted A61PA61P35/04

Quick answer

US patent 9151762 (Identification of DSG-3 as a biomarker for the detection of metastasis in lymph nodes) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P35/04